52: Alzheimer's Update--Expensive New Med vs Fasting & Keto (KetoFlex 12-3)

The FastingWell Podcast

Ben Tanner, PA-C and Ben Tanner에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Ben Tanner, PA-C and Ben Tanner 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

2+ y ago 15:37

MP3•에피소드 홈

Lecanemab (aka Leqembi) recently got full approval form the FDA for Alzheimer’s treatment, and will now be covered by Medicare. But this medication is not only expensive, it has some major health risks. In this episode, I'll break down the risks and benefits of this new medication. Then I’ll compare lecanemab to an Alzheimer's program centered around fasting and ketosis (along with a few other medical tests and treatments), developed by Dr. Dale Bredesen, author of “The End of Alzheimer’s”.
YouTube version: https://youtu.be/JpWBxxZqiwA
---Previous episode on Alzheimer’s prevention---
Video: https://youtu.be/Z2OVf_rmwOE
Podcast: https://fastingwell.com/episode22/
Blog: https://fastingwell.com/ketoflex-fasting-alzheimers/
---Dr. Bredesen's Books---
📙 The End of Alzheimer's: https://amzn.to/3DMwhmS
📘 The End of Alzheimer's Program: https://amzn.to/3NLlIVL
📗 The First Survivors of Alzheimer’s: https://amzn.to/3NNaBvj
Listen w/ a 30-day free trial on Audible: https://amzn.to/3gKo9vI
Full show notes and resources: https://fastingwell.com/episode52/